South Carolina
Requires Coverage of Comprehensive Biomarker Testing
No
Highlighted Disparity
Latino individuals in South Carolina are most likely to receive no treatment
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases in South Carolina is 57.6 and significantly higher than the national rate of 52.8.
- It ranks 33rd among all states, placing it in the average tier.
- Over the last five years, the rate of new cases in South Carolina improved by 13%.
- In 2022, the most recent year of data available for this report, the COVID-19 pandemic continued to disrupt access to medical care, including delays and reductions in cancer diagnoses and screening. This led to a decline in incidence rates for most cancers, including lung cancer, and should not be interpreted as a reduction in the underlying cancer burden.
5-Year Survival Rate:
- The percent of people alive five years after being diagnosed with lung cancer (the survival rate) in South Carolina is 26.8%, which is significantly lower than the national rate of 29.7%.
- It ranks 28th among the 39 states with survival data, placing it in the below average tier.
- Over the last five years, the survival rate in South Carolina improved by 26%.
Early Diagnosis:
- In South Carolina, 27.1% of cases are caught at an early stage, which is significantly lower than the national rate of 28.1%.
- It ranks 37th among the 50 states with data on diagnosis at an early stage, placing it in the average tier.
- Over the last five years, the early diagnosis rate in South Carolina did not change significantly.
Lung Cancer Treatment
Biomarker Coverage:
- South Carolina has yet to require any insurance coverage of comprehensive biomarker testing, including for lung cancer, as of August 2025.
Surgical Treatment:
- South Carolina ranked 30th (out of the 49 states with available data) with 18.7% of cases undergoing surgery as part of the first course of treatment.
- This is significantly lower than the national rate of 20.7% and puts South Carolina in the below average tier.
- Over the last five years, the percent of cases undergoing surgery in South Carolina improved by 12%.
No Treatment:
- South Carolina ranked 30th (out of the 49 states with available data) with 20.9% of cases not receiving any treatment.
- This is not significantly different than the national rate of 21.0% and puts South Carolina in the average tier.
- Over the last five years, the percent of cases receiving no treatment in South Carolina did not change significantly.
Screening
Screening for High Risk:
- In South Carolina, 18.8% of those at high risk were screened, which was not significantly different than the national rate of 18.2%.
- It ranks 24th among all states, placing it in the average tier.
- Screening rates in this year’s report have been updated to correct an error in the data source and should not be compared to previous reports.
Prevention
Tobacco Use:
- The 2023 smoking rate in South Carolina is 12.1% and not significantly different than the national rate of 11.4%.
- It ranks 25th among all states, placing it in the average tier.
Radon Exposure:
- In South Carolina, 10.0% of radon test results were at or above the action level recommended by EPA.
- It ranks 9th among all states, placing it in the above average tier.
Racial & Ethnic Disparities
Black individuals:
- The rate of new lung cancer cases is 51.4 per 100,000 population among Black individuals in South Carolina, significantly lower than the rate of 54.2 among Black individuals nationally, and significantly lower than the rate of 60.7 among white individuals in South Carolina.
- The five-year survival rate is 23.9% among Black individuals in South Carolina, significantly lower than the rate of 27.1% among Black individuals nationally, and significantly lower than the rate of 27.5% among white individuals in South Carolina.
- 23.5% of lung cancer cases are diagnosed at an early stage among Black individuals in South Carolina, not significantly different than the rate of 25.1% among Black individuals nationally, and significantly lower than the rate of 28.0% among white individuals in South Carolina.
- 15.2% of Black individuals with lung cancer in South Carolina underwent surgery, significantly lower than the rate of 17.1% among Black individuals nationally, and significantly lower than the rate of 19.6% among white individuals in South Carolina.
- 23.0% of Black individuals with lung cancer in South Carolina did not receive any treatment, not significantly different than the rate of 22.7% among Black individuals nationally, and significantly higher than the rate of 20.0% among white individuals in South Carolina.
Latino individuals:
- The rate of new lung cancer cases is 27.6 per 100,000 population among Latino individuals in South Carolina, not significantly different than the rate of 27.9 among Latino individuals nationally, and significantly lower than the rate of 60.7 among white individuals in South Carolina.
- State-level survival rates are not available for Latino individuals at this time. Nationally, the five-year survival rate among Latino individuals is 22.7%, not significantly different than the rate of 25.0% among white individuals.
- 18.4% of lung cancer cases are diagnosed at an early stage among Latino individuals in South Carolina, not significantly different than the rate of 23.9% among Latino individuals nationally, and significantly lower than the rate of 28.0% among white individuals in South Carolina.
- 16.2% of Latino individuals with lung cancer in South Carolina underwent surgery, significantly lower than the rate of 21.4% among Latino individuals nationally, and significantly lower than the rate of 19.6% among white individuals in South Carolina.
- 32.5% of Latino individuals with lung cancer in South Carolina did not receive any treatment, significantly higher than the rate of 25.8% among Latino individuals nationally, and significantly higher than the rate of 20.0% among white individuals in South Carolina.
Asian or Pacific Islander individuals:
- The rate of new lung cancer cases is 29.7 per 100,000 population among Asian or Pacific Islanders individuals in South Carolina, not significantly different than the rate of 32.5 among Asian or Pacific Islanders individuals nationally, and significantly lower than the rate of 60.7 among white individuals in South Carolina.
- State-level survival rates are not available for Asian or Pacific Islander individuals at this time. Nationally, the five-year survival rate among Asian or Pacific Islander individuals is 28.6% and significantly higher than the rate of 25.0% among white individuals.
- 36.3% of lung cancer cases are diagnosed at an early stage among Asian or Pacific Islander individuals in South Carolina, significantly higher than the rate of 23.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 28.0% among white individuals in South Carolina.
- 24.4% of Asian or Pacific Islander individuals with lung cancer in South Carolina underwent surgery, not significantly different than the rate of 24.7% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 19.6% among white individuals in South Carolina.
- 22.2% of Asian or Pacific Islander individuals with lung cancer in South Carolina did not receive any treatment, not significantly different than the rate of 19.8% among Asian or Pacific Islander individuals nationally, and not significantly different than the rate of 20.0% among white individuals in South Carolina.
Indigenous Peoples:
- The rate of new lung cancer cases is 41.5 per 100,000 population among Indigenous peoples (American Indians/Alaska Natives) in South Carolina, not significantly different than the rate of 39.8 among Indigenous Peoples nationally, and significantly lower than the rate of 60.7 among white individuals in South Carolina.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 22.3% and not significantly different than the rate of 25.0% among white individuals.
- Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in South Carolina due to too few cases over the time period to allow for accurate analysis.
Summary
Despite the early diagnosis rate in South Carolina falling into the average tier, the state still has a lot of work to do to make sure that more of those at high risk for lung cancer are screened.
South Carolina has yet to require any insurance coverage of comprehensive biomarker testing, which can help determine what treatment options would be best for individuals with lung cancer and other diseases.
South Carolina falls into the average tier for percent of patients receiving no treatment. Some patients do refuse treatment, but issues such as fatalism and stigma can prevent eligible patients from accessing treatment that may save or extend their lives. All patients should work with their doctors to establish a treatment plan and goals.
Page last updated: October 29, 2025
